Department of Chemical Engineering and Biomedical Engineering Interdepartmental Program University of California Los Angeles Los Angeles, California, USA
Studies on patients with sickle-cell disease now shed light on the physiological battle between hemoglobin and the vasoregulator nitric oxide. It appears that hemoglobin scavenges NO in these patients, likely contributing to vascular complications (pages 1383−1389).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
